Kuriakose Emil's Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Oct 2, 2025
- Accession no.
- 0001892413-25-000004
- Filed
- Oct 2, 2025
- Trade date
- Oct 1, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $7.41K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kuriakose EmilCIK 0001892413 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | Common Stock | SSaleDisposed | −944 | $7.85 | −$7,410.4 | 51,520 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.